Trends in Antibiotic Resistance of Escherichia coli Strains Isolated from Clinical Samples (2019–2023): A Hospital-Based Retrospective Analysis
<i>E. coli</i> strains displayed persistently high resistance to ampicillin, trimethoprim/sulfamethoxazole, and ciprofloxacin, with peaks in ESBL production and multidrug resistance during the COVID-19 pandemic. These trends underscore the importance of continuous surveillance and antibiotic stewardship, with direct implications for empirical UTI therapy and broader strategies to mitigate the public health impact of antimicrobial resistance.
Authors
- Ortansa Csutak (ORCID: https://orcid.org/0000-0001-7899-9481)
- Monica Marilena Ţânţu (ORCID: https://orcid.org/0000-0002-1038-7953)
- Corneliu Ovidiu Vrâncianu (ORCID: https://orcid.org/0000-0002-2409-0966)
- Claudia Daniela Goleanu
- Daria Adelina Goleanu
Institutions
- University of Bucharest (RO)
- Carol Davila University of Medicine and Pharmacy (RO)
- University of Pitesti (RO)
- Clinical Emergency Hospital Bucharest (RO)
- National Institute of Research and Development for Biological Sciences (RO)
- Universitatea Națională de Știință și Tehnologie Politehnica București (RO)
Publication Details
- Journal
- Pathogens
- Published
- 2025-09-13
- DOI
- https://doi.org/10.3390/pathogens14090927
- Citations
- 4
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 5.42
Funders
- Ministerul Cercetării, Inovării şi Digitalizării
- Universitatea din București